Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Oncogene. 2012 Mar 29;31(13):1636-48. doi: 10.1038/onc.2011.346. Epub 2011 Aug 15.
Desmoglein-2 (Dsg2) is a desmosomal cadherin that is aberrantly expressed in human skin carcinomas. In addition to its well-known role in mediating intercellular desmosomal adhesion, Dsg2 regulates mitogenic signaling that may promote cancer development and progression. However, the mechanisms by which Dsg2 activates these signaling pathways and the relative contribution of its signaling and adhesion functions in tumor progression are poorly understood. In this study we show that Dsg2 associates with caveolin-1 (Cav-1), the major protein of specialized membrane microdomains called caveolae, which functions in both membrane protein turnover and intracellular signaling. Sequence analysis revealed that Dsg2 contains a putative Cav-1-binding motif. A permeable competing peptide resembling the Cav-1 scaffolding domain bound to Dsg2, disrupted normal Dsg2 staining and interfered with the integrity of epithelial sheets in vitro. Additionally, we observed that Dsg2 is proteolytically processed; resulting in a 95-kDa ectodomain shed product and a 65-kDa membrane-spanning fragment, the latter of which localizes to lipid rafts along with full-length Dsg2. Disruption of lipid rafts shifted Dsg2 to the non-raft fractions, leading to the accumulation of these proteins. Interestingly, Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2. Collectively, these data are consistent with the possibility that accumulation of truncated Dsg2 protein interferes with desmosome assembly and/or maintenance to disrupt cell-cell adhesion. Furthermore, the association of Dsg2 with Cav-1 may provide a mechanism for regulating mitogenic signaling and modulating the cell-surface presentation of an important adhesion molecule, both of which could contribute to malignant transformation and tumor progression.
桥粒糖蛋白 2(Dsg2)是一种在人类皮肤癌中异常表达的桥粒钙粘蛋白。除了其在介导细胞间桥粒黏附中的众所周知的作用外,Dsg2 还调节有丝分裂信号,这些信号可能促进癌症的发展和进展。然而,Dsg2 激活这些信号通路的机制以及其信号和黏附功能在肿瘤进展中的相对贡献尚不清楚。在这项研究中,我们表明 Dsg2 与小窝蛋白-1(Cav-1)相关,Cav-1 是称为小窝的专门膜微域的主要蛋白,其功能既在于膜蛋白周转又在于细胞内信号转导。序列分析表明 Dsg2 包含一个假定的 Cav-1 结合基序。类似于 Cav-1 支架结构域的可渗透竞争肽与 Dsg2 结合,破坏了正常的 Dsg2 染色,并干扰了体外上皮片的完整性。此外,我们观察到 Dsg2 被蛋白水解加工;产生 95 kDa 的细胞外结构域脱落产物和 65 kDa 的跨膜片段,后者与全长 Dsg2 一起定位于脂筏。脂筏的破坏将 Dsg2 转移到非筏区,导致这些蛋白的积累。有趣的是,在过表达 Dsg2 的转基因小鼠的皮肤肿瘤中,体内 Dsg2 的蛋白水解产物升高。总的来说,这些数据表明,截断的 Dsg2 蛋白的积累可能干扰桥粒的组装和/或维持,从而破坏细胞间黏附。此外,Dsg2 与 Cav-1 的关联可能提供了一种调节有丝分裂信号和调节重要黏附分子的细胞表面呈现的机制,这两者都可能有助于恶性转化和肿瘤进展。